Russian Heart Failure Journal 2009year Acquired heart disorders. Some features of clinical presentation and treatment in XXI century


To access this material please log in or register

Register Authorize
2009/

Acquired heart disorders. Some features of clinical presentation and treatment in XXI century

Storogakov G. I., Tronina O. A., Gendlin G. E.

Keywords: XXI century, age, drug treatment, acquired valvular diseases, surgical treatment

DOI:

The review covers features of modern diagnostics, prevention and treatment of valvular disorders, developed after rheumatismal fever, involutional diseases and infectional endocarditis.
  1. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24 (13):1231–1243.
  2. ACC / AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.. J Am Coll Cardiol. 2006; 48 (3):e1-148.
  3. Дземешкевич С. Л., Стивенсон Л. У., Алекси-Месхишвили В. В. Болезни аортального клапана. Функция, диагностика, лечение. – М.: ГЕОТАР-Медиа, 2004. – 328 с.
  4. Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005; 352 (23):2389–2397.
  5. Mohler ER 3rd, Adam LP, McClelland P et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997; 17 (3):547‑552.
  6. Iung B, Gohlke-Bärwolf C, Tornos P et al. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002; 23 (16):1253–1266.
  7. Horstkotte D, Follath F, Gutschik E et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J. 2004; 25 (3):267‑276.
  8. Гендлин Г. Е., Новикова Н. А., Мелехов А. В. и др. Клинический разбор случая инфекционного эндокардита. Сердце. 2006; 5 (8):424‑430.
  9. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96 (3):200‑209.
  10. Шевченко Ю. Л. Гнойно-септическая кардиохирургия. В кн.: 50 лекций по хирургии. Под ред. акад. В. С. Савельева. – М.: Media Medica, 2003. – 20–26.
  11. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart. 2003; 89 (5):577‑581.
  12. Ruotsalainen E, Sammalkorpi K, Laine J et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis. 2006 Sep 11; 6:137.
  13. Гендлин Г. Е., Мелехов А. В., Сторожаков Г. И., Карабиненко А. А. Эндокардит внутривенных наркоманов. Российский медицинский журнал. 2007; 6:42–45.

To access this material please log in or register

Register Authorize
Ru En